🔗 Permalink

Inventor profile of:

Michael E. Jung

City:

Los Angeles, California

Country:

United States

Published Applications:

Last publication date:

2025-10-02

Top Assignees for applications by Michael E. Jung

The entities that hold a legal rights for patent applications filed by inventor Jung Michael E.:

The Regents of the University of California 58 Oakland, CA United States
ALNYLAM PHARMACEUTICALS, INC. 3 Cambridge, MA United States
The Board of Trustees of the University of Illinois 2 Urbana, IL United States
REGENTS OF THE UNIVERSITY OF CALIFORNIA 2 Oakland, CA United States
Pelage Pharmaceuticals, Inc. 1 Los Angeles, CA United States
Merck Sharp Dohme Corp. 1 Rahway, NJ United States
ISIS Pharmaceuticals, Inc. 1 Carlsbad, CA United States
UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. 1 Louisville, KY United States
Lawrence Livermore National Security, LLC 1 Livermore, CA United States
The United States Government represented by the Department of Veterans Affairs 1 Washington, DC United States
The United States Government, as Represented by the Department of Veterans Affairs 1 Washington, DC United States
The Regents of the University of Califronia 1 Oakland, CA United States
Tekmira Pharmaceuticals Corporation 1 Burnaby, British Columbia, Canada
McGill University 1 , Canada
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 1 Oaklnad, CA United States

Recent patent applications by Jung Michael E.

Michael E. Jung from Los Angeles, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-10-02

US20250304579A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH

#2 | 2025-06-19

US20250197383A1

Chemistry; metallurgy

SMALL MOLECULE INHIBITORS OF ENPP1

#3 | 2025-05-08

US20250145634A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING CANCER

#4 | 2024-10-03

US20240327400A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH

#5 | 2024-09-05

US20240293383A1

Human necessities

SUBSTITUTED DIAZASPIROALKANES AS ANDROGEN RECEPTOR MODULATORS

#6 | 2024-05-30

US20240174625A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING TAUOPATHIES

#7 | 2024-03-14

US20240083839A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS

#8 | 2024-02-22

US20240059654A1

Chemistry; metallurgy

INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY

#9 | 2024-02-22

US20240058340A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING CANCER

#10 | 2024-02-08

US20240043390A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING CANCER

#11 | 2024-01-25

US20240025895A1

Chemistry; metallurgy

Compositions and methods for modulating hair growth

#12 | 2023-11-16

US20230365540A1

Chemistry; metallurgy

SMALL MOLECULE INHIBITORS OF ENPP1

#13 | 2023-11-16

US20230364091A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING CANCER

#14 | 2023-10-12

US20230322765A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH

#15 | 2023-07-13

US20230218559A1

Human necessities

Compositions and Methods for Treating Aging and Age-Related Diseases and Symptoms

#16 | 2023-06-08

US20230174500A1

Chemistry; metallurgy

PRODRUGS OF ALPHA-KETOGLUTARATE, ALPHA-KETOBUTYRATE, ALPHA-KETOISOVALERATE, AND ALPHA-KETOISOHEXANOATE, AND USES THEREOF

#17 | 2023-04-13

US20230115366A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING CANCER

#18 | 2023-04-13

US20230114220A1

Chemistry; metallurgy

Compositions and methods for modulating hair growth

#19 | 2023-04-06

US20230103693A1

Chemistry; metallurgy

SYNTHESIS OF COMPOUNDS TO PROMOTE HAIR GROWTH

#20 | 2023-02-23

US20230059009A1

Chemistry; metallurgy

INHIBITORS OF LIN28 AND METHODS OF USE THEREOF

#21 | 2022-12-01

US20220380298A1

Chemistry; metallurgy

Inhibitors of the n-terminal domain of the androgen receptor

#22 | 2022-09-29

US20220305006A1

Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND DISORDERS

#23 | 2022-09-01

US20220274929A1

Chemistry; metallurgy

THIOSEMICARBAZONE COMPOUNDS AND USES THEREOF

#24 | 2022-08-11

US20220251054A1

Chemistry; metallurgy

Analogues and Methods of Treating Rett Syndrome

#25 | 2022-06-09

US20220177418A1

Chemistry; metallurgy

INHIBITORS OF THE N-TERMINAL DOMAIN OF THE ANDROGEN RECEPTOR

#26 | 2022-05-19

US20220153738A1

Chemistry; metallurgy

Compositions and methods for modulating hair growth

#27 | 2022-05-05

US20220133747A1

Human necessities

ESTROGEN RECEPTOR INHIBITORS AND USES THEROF

#28 | 2022-04-21

US20220119384A1

Chemistry; metallurgy

Potent antiviral pyrazolopyridine compounds

#29 | 2022-03-03

US20220064177A1

Chemistry; metallurgy

Compositions and methods for treating cancer

#30 | 2022-02-17

US20220048908A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH

#31 | 2022-02-10

US20220041553A1

Chemistry; metallurgy

APOE4-TARGETED THERAPUTICS THAT INCREASE SIRT1

#32 | 2021-12-02

US20210371384A1

Chemistry; metallurgy

Inhibitors of the WNT/beta-catenin pathway

#33 | 2021-10-07

US20210309634A1

Chemistry; metallurgy

Compositions and methods for treating epigenetic disease

#34 | 2021-07-22

US20210220331A1

Human necessities

INHIBITORS OF IRES-MEDIATED PROTEIN SYNTHESIS

#35 | 2021-07-01

US20210196667A1

Human necessities

Estrogen receptor ligands, compositions and methods related thereto

#36 | 2021-06-24

US20210188763A1

Chemistry; metallurgy

COMPOUNDS AND METHODS FOR HEMATOPOIETIC REGENERATION

#37 | 2021-04-29

US20210121450A1

Human necessities

Substituted diazaspiroalkanes as androgen receptor modulators

#38 | 2020-10-15

US20200325113A1

Chemistry; metallurgy

Prodrugs of alpha-ketoglutarate, alpha-ketobutyrate, alpha-ketoisovalerate, and alpha-ketoisohexanoate, and uses thereof

#39 | 2020-09-17

US20200290978A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING CANCER

#40 | 2020-07-16

US20200223842A1

Chemistry; metallurgy

Substituted pyrrolo[2,3-b]pyridines, pyrazolo[3,4-d]pyrimidines and [1,2,3]triazolo[4,5-b]pyridines as potent antivirals

#41 | 2020-05-21

US20200157093A1

Chemistry; metallurgy

Compositions and methods for modulating hair growth

#42 | 2019-12-19

US20190382335A1

Chemistry; metallurgy

Inhibitors of the N-terminal domain of the androgen receptor

#43 | 2019-10-31

US20190330142A1

Chemistry; metallurgy

INHIBITORS OF MTOR-DEPTOR INTERACTIONS AND METHODS OF USE THEREOF

#44 | 2019-09-26

US20190292132A1

Chemistry; metallurgy

Compounds and methods for hematopoietic regeneration

#45 | 2019-06-27

US20190192476A1

Human necessities

Estrogen receptor ligands, compositions and methods related thereto

#46 | 2019-06-27

US20190192470A1

Human necessities

Compositions and Methods for Treating Aging and Age-Related Diseases and Symptoms

#47 | 2019-06-13

US20190175614A1

Human necessities

Estrogen receptor modulator combinations

#48 | 2018-11-08

US20180318276A1

Human necessities

Substituted diazaspiroalkanes as androgen receptor modulators

#49 | 2018-10-04

US20180280346A1

Human necessities

Compositions and methods for treating cancer

#50 | 2018-09-27

US20180273527A1

Chemistry; metallurgy

Potent antiviral pyrazolopyridine compounds

#51 | 2018-03-29

US20180086787A1

Chemistry; metallurgy

Estrogen receptor modulators

#52 | 2017-08-10

US20170226059A1

Chemistry; metallurgy

APOE4-TARGETED THERAPUTICS THAT INCREASE SIRT1

#53 | 2017-07-20

US20170204090A1

Chemistry; metallurgy

Deoxycytidine kinase inhibitors

#54 | 2017-01-19

US20170014399A1

Human necessities

Substituted diazaspiroalkanes as androgen receptor modulators

#55 | 2016-12-08

US20160354334A1

Human necessities

Compositions and Methods for Treating Aging and Age-Related Diseases and Symptoms

#56 | 2016-08-18

US20160237076A1

Chemistry; metallurgy

Deoxycytidine kinase inhibitors

#57 | 2016-07-21

US20160207908A1

Chemistry; metallurgy

BROAD SPECTRUM ANTIVIRAL AND ANTIPARASITIC AGENTS

#58 | 2016-06-09

US20160159850A1

Chemistry; metallurgy

Bone-selective osteogenic oxysterol-bone targeting agents

#59 | 2016-05-19

US20160137662A1

Chemistry; metallurgy

Compositions and methods for treating cancer

#60 | 2016-01-21

US20160016930A1

Chemistry; metallurgy

Protective molecules against anthrax toxin

#61 | 2015-09-03

US20150246934A1

Chemistry; metallurgy

Tricyclic Gyrase inhibitors

#62 | 2015-06-11

US20150158832A1

Chemistry; metallurgy

Compounds and methods of treating cancer

#63 | 2015-05-14

US20150133777A1

Human necessities

Positron emission tomography probe to monitor selected sugar metabolism in vivo

#64 | 2015-04-30

US20150118277A1

Human necessities

Oxysterol analogue OXY133 induces osteogenesis and hedgehog signaling and inhibits adipogenesis

#65 | 2015-03-05

US20150065546A1

Chemistry; metallurgy

Diarylhydantoin compounds

#66 | 2015-02-19

US20150051251A1

Chemistry; metallurgy

Premature-termination-codons readthrough compounds

#67 | 2015-01-29

US20150031725A1

Chemistry; metallurgy

Compositions and methods for treating cancer

#68 | 2015-01-15

US20150018398A1

Human necessities

METHODS OF USING ESTROGEN RECEPTOR-BETA LIGANDS AS RADIATION MITIGATORS

#69 | 2014-11-20

US20140343111A1

Chemistry; metallurgy

DIARYLTHIOHYDANTOIN COMPOUNDS

#70 | 2014-10-16

US20140309262A1

Chemistry; metallurgy

Substituted diazaspiroalkanes as androgen receptor modulators

#71 | 2013-09-05

US20130231518A1

Chemistry; metallurgy

Compounds and compositions for mitigating tissue damage and lethality

#72 | 2013-03-21

US20130072511A1

Human necessities

Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases

#73 | 2013-02-07

US20130034501A1

Chemistry; metallurgy

DIARYLHYDANTOIN COMPOUNDS

#74 | 2013-01-31

US20130028966A1

Chemistry; metallurgy

Broad spectrum antiviral and antiparasitic agents

#75 | 2012-11-22

US20120295944A1

Chemistry; metallurgy

Treatment of hyperproliferative disorders with diarylhydantoin compounds

#76 | 2012-08-30

US20120219613A1

Chemistry; metallurgy

Novel Antiviral Agents for Enveloped Viruses

#77 | 2012-07-26

US20120190718A1

Chemistry; metallurgy

Diarylthiohydantoin compounds

#78 | 2012-06-14

US20120149710A1

Chemistry; metallurgy

SORTASE A INHIBITORS

#79 | 2012-05-24

US20120128760A1

Human necessities

Lipid compositions

#80 | 2011-01-13

US20110008297A1

Human necessities

Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and Wnt signaling

#81 | 2011-01-06

US20110003839A1

Human necessities

Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases

#82 | 2010-08-19

US20100210665A1

Chemistry; metallurgy

DIARYLHYDANTOIN COMPOUNDS

#83 | 2010-07-08

US20100172975A1

Chemistry; metallurgy

Treatment of hyperproliferative disorders with diarylhydantoin compounds

#84 | 2010-05-06

US20100112030A1

Human necessities

ROLE OF HEDGEHOG SIGNALING IN ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE

#85 | 2010-04-29

US20100105645A1

Human necessities

Inhibition of PPAR gamma expression by specific osteogenic oxysterols

#86 | 2010-02-11

US20100034781A1

Chemistry; metallurgy

Oxysterol compounds and the hedgehog pathway

#87 | 2009-07-23

US20090187027A1

Chemistry; metallurgy

Processes and reagents for sulfurization of oligonucleotides

#88 | 2009-04-30

US20090111864A1

Chemistry; metallurgy

Diarylhydantoin compounds

#89 | 2009-01-01

US20090005549A1

Chemistry; metallurgy

Processes and reagents for desilylation of oligonucleotides

#90 | 2008-06-12

US20080139634A2

Chemistry; metallurgy

Diarylthiohydantoin compounds

#91 | 2008-04-17

US20080090888A2

Human necessities

Methods and materials for assessing prostate cancer therapies and compounds

#92 | 2007-11-01

US20070254933A1

Chemistry; metallurgy

Diarylthiohydantoin compounds

#93 | 2007-08-16

US20070191443A1

Human necessities

Methods and materials for assessing prostate cancer therapies and compounds

#94 | 2007-01-04

US20070004753A1

Chemistry; metallurgy

Diarylhydantoin compounds

#95 | 2006-05-23

US10163439

Oligonucleotides having alkylphosphonate linkages and methods for their preparation

#96 | 2005-12-01

US20050267300A1

Chemistry; metallurgy

Processes and reagents for oligonucleotide synthesis and purification

InventorID:

66037 ⎘